259
Views
0
CrossRef citations to date
0
Altmetric
Letters to the editor: Original Scientific Contribution

Valacyclovir neurotoxicity and kinetics in a patient with impaired kidney function

, , ORCID Icon & ORCID Icon
Pages 1062-1063 | Received 15 Aug 2023, Accepted 23 Nov 2023, Published online: 08 Jan 2024

References

  • Brandariz-Nunez D, Correas-Sanahuja M, Maya-Gallego S, et al. Neurotoxicity associated with acyclovir and valacyclovir: a systematic review of cases. J Clin Pharm Ther. 2021;46(4):918–926. doi: 10.1111/jcpt.13464.
  • Hellden A, Odar-Cederlof I, Diener P, et al. High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational study. Nephrol Dial Transplant. 2003;18(6):1135–1141. doi:10.1093/ndt/gfg119.
  • Leikin JB, Shicker L, Orlowski J, et al. Hemodialysis removal of acyclovir. Vet Hum Toxicol. 1995;37(3):233–234.
  • Khajehdehi P, Jamal JA, Bastani B. Removal of acyclovir during continuous veno-venous hemodialysis and hemodiafiltration with high-efficiency membranes. Clin Nephrol. 2000;54(4):351–355.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.